Business Context and Reporting Period
Company: TherapeuticsMD, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: March 7, 2016
Event: Regulation FD Disclosure (Item 7.01) regarding an investor presentation.
Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report serves solely to disclose the furnishing of an investor presentation (Exhibit 99.1) and does not contain audited or unaudited financial statements.
Material Changes
No material changes to financial performance or operations are detailed in the text of this filing. The document references an investor presentation that may contain such information, but the presentation itself is an exhibit and its contents are not summarized in the filing text provided.
Guidance, Outlook, and Risks
Management Commentary: The company is furnishing an investor presentation dated March 7, 2016, for use in meetings with investors or analysts.
Legal Status: The information in this report and its exhibits is not deemed "filed" under Section 18 of the Securities Exchange Act of 1934 and is not subject to the liabilities of that section. It will not be incorporated by reference into other filings unless expressly stated.
Key Facts for Investor Verification
- Verify the contents of Exhibit 99.1 (Investor Presentation dated March 7, 2016) for specific financial data and strategic outlook.
- Confirm that the presentation is subject to modification before use in subsequent meetings.
- Note that this 8-K filing does not constitute a formal filing of the presentation's data for liability purposes under Section 18 of the Exchange Act.